Not investment advice. Educational platform. See Disclaimer.
NYSE: BMY
Bristol-Myers Squibb Company
Healthcare | Drug Manufacturers - General
$58.71+0.00 (+0.00%)as of 2026-07-15 02:07 UTC
Market Cap$119.7B
EPS (TTM)$3.46
Bristol-Myers Squibb Company (NYSE: BMY) is a $119.7B drug manufacturers - general company trading at $58.71 — 17.0× trailing earnings, yielding 4.21%. Figures from SEC EDGAR and market feeds; updated 2026-07-15 02:07 UTC.
52-Week Range
Low $42.52High $62.89
What Bristol-Myers Squibb Company does
Bristol-Myers Squibb is a biopharmaceutical company incorporated in Delaware in 1933 that discovers, develops, manufactures, and sells innovative medicines for serious diseases including oncology, hematology, immunology, cardiovascular, and neuroscience conditions. The company operates as a single business segment and competes with other research-based pharmaceutical companies, generic manufacturers, and smaller biotech firms.
Summarized from Bristol-Myers Squibb Company’s SEC filings · Read the filing ↗
Bristol-Myers Squibb is a biopharmaceutical company incorporated in Delaware in 1933 that discovers, develops, manufactures, and sells innovative medicines for serious diseases including oncology, hematology, immunology, cardiovascular, and neuroscience conditions.
What is BMY's valuation?
BMY trades at $58.71, 16.97× trailing earnings, as of 2026-07-15. It carries a 4.21% dividend yield.
When did BMY last file with the SEC?
Bristol-Myers Squibb Company's most recent SEC filing on record is a 8-K filed 2026-05-08. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-15 02:07 UTC. This page is also available as JSON at /api/data?ticker=BMY and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for BMY and 3,500+ tickers.
